Subtle Medical raises $33M to advance AI image software

Funding
Subtle Medical has raised $33m and appointed a new CEO to advance commercialisation activities surrounding its artificial intelligence (AI)-based medical imaging software. The California-based company’s Series C financing round was led by Morgan Stanley Expansion...

Subtle Medical raises $33M to advance AI image software

Funding
Subtle Medical has raised $33m and appointed a new CEO to advance commercialisation activities surrounding its artificial intelligence (AI)-based medical imaging software. The California-based company’s...

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Clinical Trials
Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Reach Surgical receives CE Mark approval for SOUND REACH Swift

Regulatory Approvals
Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears designed for open surgical...

Genesee BioMedical receives FDA 510(k) clearance for ATLAAS device

Regulatory Approvals
Genesee BioMedical, Inc., a medical device company with decades of experience designing, manufacturing, and commercializing technologies for cardiac surgery, announced today the U.S. Food...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Reflow Medical has positive data for coronary drug-eluting stent

Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable stent system. San Clemente, California-based Reflow designed its...

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

Innovation

Regulatory Approvals

Subtle Medical raises $33M to advance AI image software

Subtle Medical has raised $33m and appointed a new CEO to advance commercialisation activities surrounding its artificial intelligence (AI)-based medical imaging software. The California-based company’s...

Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart

Picard Medical, parent company of SynCardia, announced the completion of an in vivo study of its Emperor platform. The company completed an acute in vivo...

Reach Surgical receives CE Mark approval for SOUND REACH Swift

Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears designed for open surgical...

Genesee BioMedical receives FDA 510(k) clearance for ATLAAS device

Genesee BioMedical, Inc., a medical device company with decades of experience designing, manufacturing, and commercializing technologies for cardiac surgery, announced today the U.S. Food...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1146Regulatory Approvals1021Innovation655Clinical Trials523Mergers & Acquisitions509GS Funding Tracker51